Physician profile
Jacques P Fontaine
NPI 1205028867
$629,566.58
in general payments reported to CMS, 2019-2025
22 companies · $109K in 2025
The $109K reported for 2025 was more than what 99% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60K · 2020: $75K · 2021: $93K · 2022: $53K · 2023: $118K · 2024: $120K · 2025: $109K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $166K · Honoraria: $85K · Travel and Lodging: $42K · Consulting Fee: $25K · Education: $23K · Food and Beverage: $8,308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $165,918.75 |
| Honoraria | $84,800.00 |
| Travel and Lodging | $41,645.62 |
| Consulting Fee | $24,952.82 |
| Education | $22,578.75 |
| Food and Beverage | $8,307.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $169,966.58 | 2019-2025 | Imfinzi, Tagrisso |
| Intuitive Surgical, INC. | $167,364.60 | 2019-2025 | Da Vinci Sp, Da Vinci Surgical System |
| E.R. Squibb & Sons, L.L.C. | $138,757.16 | 2023-2025 | Opdivo |
| Davol INC. | $130,734.43 | 2019-2025 | Arista, Arista Ah Flexitip, Progel Applicator Spray Tips |
| Baxter Healthcare | $14,515.22 | 2023-2024 | Coseal, Hemopatch, Peri-Strips Dry |
| Medical Device Business Services, INC. | $3,182.58 | 2024 | Echelon Flex |
| Atricure, INC. | $1,264.48 | 2022-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atricure Cryoice Cryosphere Cryoablation System |
| Medtronic, INC. | $831.86 | 2022-2025 | Signet, Eea |
| Biom'Up France Sas | $518.40 | 2020-2021 | |
| Novocure INC. | $500.00 | 2020 | |
| Medela LLC | $306.38 | 2024 | Art. 101030215 Thopaz+ Chest Drainage |
| Boston Scientific Corporation | $255.81 | 2020-2022 | |
| On Target Laboratories, INC | $240.35 | 2025 | Cytalux |
| C. R. Bard, INC. & Subsidiaries | $188.80 | 2019 | |
| Becton, Dickinson and Company | $162.03 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexington Medical, INC. | $149.80 | 2025 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Olympus America INC. | $136.98 | 2022 | |
| Karl Storz Endoscopy-America | $131.86 | 2021 | |
| Celgene Corporation | $125.89 | 2022 | |
| Genentech USA, INC. | $93.77 | 2024-2025 | Tecentriq, Alecensa |
| Depuy Synthes Sales INC. | $80.79 | 2021 | |
| Nonin Medical, INC. | $58.81 | 2022-2023 | Nonin Oximetry |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacques Fontaine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.